These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35181389)

  • 1. Bipolar disorder, mood stabilizers and cognitive flexibility: Translationally dissecting illness from drug effects.
    Anyfandi E; Owens DA; Psarros C; Ferentinos P; Nikolakopoulou M; Kalogerakou S; Papakosta VM; Tsaltas E
    Behav Brain Res; 2022 Apr; 424():113799. PubMed ID: 35181389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
    Valvassori SS; Rezin GT; Ferreira CL; Moretti M; Gonçalves CL; Cardoso MR; Streck EL; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Oct; 44(14):903-9. PubMed ID: 20334877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
    Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
    Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lithium and valproate on behavioral parameters and neurotrophic factor levels in an animal model of mania induced by paradoxical sleep deprivation.
    Dal-Pont GC; Jório MTS; Resende WR; Gava FF; Aguiar-Geraldo JM; Possamai-Della T; Peper-Nascimento J; Quevedo J; Valvassori SS
    J Psychiatr Res; 2019 Dec; 119():76-83. PubMed ID: 31574363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.
    García-Blanco A; García-Portilla MP; Fuente-Tomás L; Batalla M; Sánchez-Autet M; Arranz B; Safont G; Arqués S; Livianos L; Sierra P
    J Sex Med; 2020 May; 17(5):930-940. PubMed ID: 32139195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A focus on valproate and cognitive deficits in Bipolar Disorders: A mini-review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD.
    Pigoni A; Mandolini GM; Delvecchio G; Bressi C; Soares JC; Brambilla P
    J Affect Disord; 2020 Jan; 261():277-281. PubMed ID: 31421858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
    Peselow ED; Clevenger S; IsHak WW
    Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers.
    Li L; Ji E; Han X; Tang F; Bai Y; Peng D; Fang Y; Zhang S; Zhang Z; Yang H
    Brain Imaging Behav; 2019 Oct; 13(5):1255-1264. PubMed ID: 30145720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.
    Zhuo C; Zhou C; Tian H; Li Q; Chen J; Yang L; Zhang Q; Li R; Ma X; Cai Z; Chen G; Xu Y; Song X
    Transl Psychiatry; 2022 Sep; 12(1):359. PubMed ID: 36055984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
    de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
    J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.
    Cancelier K; Gomes LM; Carvalho-Silva M; Teixeira LJ; Rebelo J; Mota IT; Arent CO; Mariot E; Kist LW; Bogo MR; Quevedo J; Scaini G; Streck EL
    Mol Neurobiol; 2017 Aug; 54(6):3935-3947. PubMed ID: 27246566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine.
    Varela RB; Valvassori SS; Lopes-Borges J; Fraga DB; Resende WR; Arent CO; Zugno AI; Quevedo J
    Psychiatry Res; 2013 Sep; 209(2):229-34. PubMed ID: 23245536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study.
    Muralidharan K; Kozicky JM; Bücker J; Silveira LE; Torres IJ; Yatham LN
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):223-30. PubMed ID: 25261261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.